Myocardial Infarction News and Research

RSS

$Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction$

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Dapagliflozin reduces the risks of death and cardiovascular events in patients with heart failure regardless of ejection fraction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was associated with a reduction in the risk of death by 49% and in the incidence of hospitalization for influenza or pneumonia by 64% compared with standard-dose vaccination.

28 Aug 2022

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

A randomized trial in more than 45,000 men has suggested that cardiovascular screening including cardiac imaging, blood pressure measurement and blood tests, plus treatment if needed, may lower the risk of death, heart attack and stroke in 65 to 69 year-olds.

28 Aug 2022

Study compares the benefits of taking antihypertensive medication in the morning or evening

A pragmatic randomised trial in more than 21,000 patients with high blood pressure followed for over five years has concluded that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening.

26 Aug 2022

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

A heart check-up is recommended in even apparently healthy people over 65 years of age before intermediate- or high-risk non-cardiac surgery, according to European Society of Cardiology (ESC) Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery published online today in European Heart Journal.

26 Aug 2022

Basic life support training essential for all people to improve survival from cardiac arrest

Basic life support training in schools and communities is essential to improve survival from cardiac arrest, according to European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal.

26 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Severe COVID-19 increases risk of future cardiovascular events

A recent study determines the relationship between COVID-19 severity and risk of subsequent cardiovascular events in a large cohort.

24 Aug 2022

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Targeting Na+/K+ ATPase alpha 1 (ATP1A1) subunit proteins could help identify novel therapies for addressing blood clots and thrombosis, according to a new study by Marshall University researchers.

24 Aug 2022

Research shows a correlation between air pollution and heart attacks in non-smokers

Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.

23 Aug 2022

What is the association between COVID-19 and thrombotic events?

In a new study, researchers assessed the association of COVID-19 and influenza with thrombotic events among patients.

18 Aug 2022

Study identifies the link between a gene variant and protection against coronary atherosclerosis

The protective effect of the newly discovered variant against coronary heart disease is likely to be caused by the below-average arterial stiffness of variant carriers.

17 Aug 2022

Researchers unravel a novel molecular target of eicosapentaenoic acid

Eicosapentaenoic acid (EPA) is an essential nutrient belonging to the omega-3 group of polyunsaturated fatty acids (PUFAs). As the human body cannot synthesize PUFAs, dietary supplements containing EPA are required for normal physiological functions. Found abundantly in natural sources like fish, hemp oil, and linseed oil, EPA is known to exhibit anti-inflammatory, neuroprotective, and cardiovascular protective activities.

9 Aug 2022

Myocardial Infarction News and Research

Research shows benefit of dapagliflozin for heart failure patients regardless of ejection fraction

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

High-dose influenza vaccination in older adults leads to reductions in hospitalizations, all-cause mortality

Cardiovascular screening may lower the risk of death, heart attack and stroke in 65 to 69 year-olds

Study compares the benefits of taking antihypertensive medication in the morning or evening

Healthy people over 65 years of age recommended to get a heart check-up before non-cardiac surgery

Basic life support training essential for all people to improve survival from cardiac arrest

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Severe COVID-19 increases risk of future cardiovascular events

Targeting Na+/K+ ATPase alpha 1 proteins could help identify novel therapies for blood clots, thrombosis

Research shows a correlation between air pollution and heart attacks in non-smokers

What is the association between COVID-19 and thrombotic events?

Study identifies the link between a gene variant and protection against coronary atherosclerosis

Researchers unravel a novel molecular target of eicosapentaenoic acid

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign

Experiments and mathematical modeling help study the role of morphogens in tissue patterning

IRB Barcelona researchers discover genetic drivers of clonal hematopoiesis

Human anti-desmoglein 2 levels are associated with COVID-19 severity

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News